NCT05758389 2025-09-05
Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Recruiting
Clinical Trials
10 trialsNCT07010120 2025-06-13
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 1/2 Recruiting
NCT06673693 2025-04-16
NEOSTART
Sun Yat-sen University
Phase 2 Recruiting
NCT06258811 2025-03-13
Neoadjuvant Immunochemotherapy for LAOSCC
Huashan Hospital
Phase 3 Recruiting
NCT06741982 2024-12-19
A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
West China Hospital
Phase 1 Recruiting
NCT06383780 2024-07-16
Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
Sun Yat-sen University
Phase 3 Recruiting
NCT05862168 2023-07-17
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial
Zhejiang University
Phase 2 Recruiting
NCT05343325 2022-12-29
The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2 Recruiting
NCT05595590 2022-10-27
Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT05342792 2022-04-25
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Recruiting